Speech-Language Pathologists in Glen Oaks, NY Accepting Medicare

6 Speech-Language Pathologists found. Showing 1 - 6

Sajitha Mahmood Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 26059 Union Tpke Apt 2, Glen Oaks, NY 11004 Phone: 718-805-2774

Mrs. Kathryn Ann Gaven, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7345 Little Neck Pkwy, Glen Oaks, NY 11004 Phone: 516-644-8179

Mrs. Sara Anne Rios Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8051 261st St, Glen Oaks, NY 11004 Phone: 718-831-4010

Mrs. Lisa D Adragna, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7229 Little Neck Pkwy, Glen Oaks, NY 11004 Phone: 718-343-3107

Nicolette Pullo, M.S, SLP-CF Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 25522 74th Ave, Glen Oaks, NY 11004 Phone: 516-680-9496

Ms. Laura Angela Accardi, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 73-01 236rd St, Glen Oaks, NY 11004 Phone: 516-941-8584    Fax: 718-343-4310

News Archive

Newly created line of skin care products based on ISCO's proprietary Parthenogenic Stem Cells

Lifeline Skin Care, Inc, a wholly owned subsidiary of International Stem Cell Corporation, announced today that it has retained the services of a highly experienced expert in the skin care industry, Raulee Marcus, to help design a marketing program for its newly created line of skin care products based on ISCO's proprietary Parthenogenic Stem Cells.

Alzheimer's may progress more rapidly in people with high blood pressure or atrial fibrillation

While current medications for Alzheimer's disease are effective for some patients in slowing the rate of AD progression, many patients do not benefit from the treatments or cannot tolerate them, says lead researcher Michelle M. Mielke, Ph.D., of the Department of Psychiatry and Behavioral Sciences at The Johns Hopkins University School of Medicine.

Kravis Children's Hospital named one of country's top children's hospitals in pediatric specialties

The Kravis Children's Hospital at Mount Sinai ranked again among the country's top children's hospitals in pediatric specialties, according to the newly issued U.S. News & World Report's "Best Children's Hospitals" guidebook for 2015-2016.

ASTMH symposium illustrates the need to generate new medicines for infectious diseases

An urgent need for new medicines to treat neglected infectious diseases in the developing world has prompted a growing number of collaborations among academic researchers, non-profit product development partnerships (PDPs), and pharmaceutical and biotechnology companies.

Results from Roche's trastuzumab emtansine Phase III trial on HER2-positive breast cancer

ImmunoGen, Inc., a biotechnology company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced that Roche has reported that updated results from its EMILIA Phase III trial show that patients treated with trastuzumab emtansine had a significant improvement in OS compared to those randomized to standard-of-care therapy.

Read more Medical News

› Verified 1 days ago